GlassScriptPhysician profile
Suchita Varhade
NPI 1518351402
$1,189.04
in general payments reported to CMS, 2019-2025
15 companies · $29.61 in 2025
The $29.61 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $270 · 2021: $131 · 2022: $286 · 2023: $211 · 2024: $28.44 · 2025: $29.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.83 | 2019-2020 | |
| Therapeuticsmd, INC. | $141.39 | 2019-2022 | |
| Pfizer INC. | $127.32 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $103.81 | 2021-2022 | |
| Minerva Surgical, INC | $91.69 | 2022-2023 | |
| Hologic Sales and Service, LLC | $90.84 | 2021-2024 | Novasure, Myosure Tissue Removal Device, Aptima |
| Organon LLC | $87.37 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $76.55 | 2022 | |
| Merck Sharp & Dohme LLC | $61.82 | 2019-2021 | |
| Exeltis, USA INC. | $42.00 | 2019-2024 | Slynd |
| Meditrina | $21.96 | 2021 | |
| Ethicon US, LLC | $21.37 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.70 | 2022 | |
| Scynexis, INC. | $17.01 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suchita Varhade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.